These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8750149)

  • 1. Evidence for a mutual regulation of p53 and c-myc expression in human colorectal cancer metastases.
    Rochlitz CF; Heide I; Thiede C; Herrmann R; de Kant E
    Ann Oncol; 1995 Dec; 6(10):981-6. PubMed ID: 8750149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression and amplification of c-myc during progression of human colorectal cancer.
    Rochlitz CF; Herrmann R; de Kant E
    Oncology; 1996; 53(6):448-54. PubMed ID: 8960139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MDR1 expression correlates with mutant p53 expression in colorectal cancer metastases.
    de Kant E; Heide I; Thiede C; Herrmann R; Rochlitz CF
    J Cancer Res Clin Oncol; 1996; 122(11):671-5. PubMed ID: 8898977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fish detected p53 deletion and N-MYC amplification in colorectal cancer.
    Ozakyol A; Ozdemir M; Artan S
    Hepatogastroenterology; 2006; 53(68):192-5. PubMed ID: 16608022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneous expression and association of beta-catenin, p16 and c-myc in multistage colorectal tumorigenesis and progression detected by tissue microarray.
    Xie D; Sham JS; Zeng WF; Lin HL; Che LH; Wu HX; Wen JM; Fang Y; Hu L; Guan XY
    Int J Cancer; 2003 Dec; 107(6):896-902. PubMed ID: 14601048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of the c-myc proto-oncogene in colorectal carcinoma is associated with a reduced mortality that is abrogated by point mutation of the p53 tumor suppressor gene.
    Smith DR; Goh HS
    Clin Cancer Res; 1996 Jun; 2(6):1049-53. PubMed ID: 9816266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-myc mRNA overexpression is associated with lymph node metastasis in colorectal cancer.
    Sato K; Miyahara M; Saito T; Kobayashi M
    Eur J Cancer; 1994; 30A(8):1113-7. PubMed ID: 7654441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 genetic abnormalities and myc activation in human lung carcinoma.
    Gazzeri S; Brambilla E; Caron de Fromentel C; Gouyer V; Moro D; Perron P; Berger F; Brambilla C
    Int J Cancer; 1994 Jul; 58(1):24-32. PubMed ID: 8014012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysfunction of p53 pathway in human colorectal cancer: analysis of p53 gene mutation and the expression of the p53-associated factors p14ARF, p33ING1, p21WAF1 and MDM2.
    Tachibana M; Kawamata H; Fujimori T; Omotehara F; Horiuchi H; Ohkura Y; Igarashi S; Kotake K; Kubota K
    Int J Oncol; 2004 Oct; 25(4):913-20. PubMed ID: 15375540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No correlation of c-myc overexpression and p53 mutations in liposarcomas.
    Schneider-Stock R; Walter H; Rys J; Radig K; Hoang-Vu C; Roessner A
    Virchows Arch; 1998 Oct; 433(4):315-21. PubMed ID: 9808433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated protein expression of cyclin D1 and Fra-1 but decreased expression of c-Myc in human colorectal adenocarcinomas overexpressing beta-catenin.
    Wang HL; Wang J; Xiao SY; Haydon R; Stoiber D; He TC; Bissonnette M; Hart J
    Int J Cancer; 2002 Oct; 101(4):301-10. PubMed ID: 12209953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-myc, p53 and bcl-2, apoptosis-related genes in infiltrating breast carcinomas: evidence of a link between bcl-2 protein over-expression and a lower risk of metastasis and death in operable patients.
    Lê MG; Mathieu MC; Douc-Rasy S; Le Bihan ML; Adb El All H; Spielmann M; Riou G
    Int J Cancer; 1999 Dec; 84(6):562-7. PubMed ID: 10567899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of p53 mutations, microvessel density and neoangiogenesis in pairs of colorectal cancers and corresponding liver metastases.
    Kern A; Taubert H; Scheele J; Rudroff C; Mothes H; Kappler M; Bartel F; Richter KK
    Int J Oncol; 2002 Aug; 21(2):243-9. PubMed ID: 12118317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic dissimilarity between primary colorectal carcinomas and their lymph node metastases: ploidy, p53, bcl-2, and c-myc expression--a pilot study.
    Zalata KR; Elshal MF; Foda AA; Shoma A
    Tumour Biol; 2015 Aug; 36(8):6579-84. PubMed ID: 25840688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression and significance of telomerase reverse transcriptase and its regulators in non-small cell lung carcinoma].
    Chen TX; Xiong YY; Liu L
    Ai Zheng; 2004 Mar; 23(3):273-7. PubMed ID: 15025956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. bcl-2 expression is reciprocal to p53 and c-myc expression in metastatic human colorectal cancer.
    Popescu RA; Lohri A; de Kant E; Thiede C; Reuter J; Herrmann R; Rochlitz CF
    Eur J Cancer; 1998 Jul; 34(8):1268-73. PubMed ID: 9849490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of p53 and c-myc overrepresentation in stage T(2-3)N(1-3)M(0) prostate cancer are potential markers for cancer progression.
    Qian J; Hirasawa K; Bostwick DG; Bergstralh EJ; Slezak JM; Anderl KL; Borell TJ; Lieber MM; Jenkins RB
    Mod Pathol; 2002 Jan; 15(1):35-44. PubMed ID: 11796839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moderate amplifications of the c-myc gene correlate with molecular and clinicopathological parameters in colorectal cancer.
    Masramon L; Arribas R; Tórtola S; Perucho M; Peinado MA
    Br J Cancer; 1998 Jun; 77(12):2349-56. PubMed ID: 9649157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p14ARF homozygous deletion or MDM2 overexpression in Burkitt lymphoma lines carrying wild type p53.
    Lindström MS; Klangby U; Wiman KG
    Oncogene; 2001 Apr; 20(17):2171-7. PubMed ID: 11360201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of the RP-MDM2-p53 pathway accelerates APC loss-induced colorectal tumorigenesis.
    Liu S; Tackmann NR; Yang J; Zhang Y
    Oncogene; 2017 Mar; 36(10):1374-1383. PubMed ID: 27617574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.